The contract development and manufacturing organization (CDMO) sector stands at a critical juncture as global economic policies, particularly U.S. tariffs, cast a shadow over various industries. With tariffs often designed to protect domestic markets, their ripple effects could reshape supply
In the intricate world of pharmaceutical regulation, a lingering debate continues to challenge industry standards and scientific rationale, particularly around the mandatory testing for alkyl sulfonate ester contaminants in sulfonate-salt drugs across Europe and the UK. These compounds, flagged as
Imagine a world where a single 3D printing file format can seamlessly bridge the gap between design and production, eliminating errors and ensuring consistency across diverse technologies and industries. This is no longer a distant dream but a reality with the 3D Manufacturing Format (3MF), a
In a striking reaction to President Donald Trump’s aggressive tariff threats designed to ramp up domestic production, pharmaceutical powerhouses are channeling billions into expanding manufacturing within the United States, signaling a major shift in response to political pressure. Industry leaders
In the ever-evolving landscape of pharmaceuticals, pharmacovigilance (PV) stands as a cornerstone of patient safety, tasked with the critical mission of monitoring and assessing adverse events (AEs) linked to drugs, while traditional approaches struggle under escalating workloads and regulatory
AstraZeneca, a major UK-based pharmaceutical company, has committed to a transformative $50 billion investment in its U.S. operations. This strategic initiative focuses on enhancing its manufacturing and research capabilities, aiming to secure a significant share of the American market by
